Drug Induced Hypoprolactinemia

Overview

Journal Rev Endocr Metab Disord

Publisher Springer

Specialty Endocrinology

Date 2024 Sep 23

PMID 39312063

Authors

Adriana G Ioachimescu

Fahrettin Kelestimur

Affiliations

Soon will be listed here.

Abstract

Prolactin levels can be influenced by multiple medications primarily through the interaction with dopamine receptors which regulate its secretion. Unlike hyperprolactinemia which has a well-defined clinical phenotype, the effects of hypoprolactinemia beyond inability to lactate are incompletely understood. Recent studies have raised concerns regarding detrimental changes in glucose metabolism, sexual function and psychological profile in patients with low prolactin levels. In contrast with anatomic and genetic etiologies, drug-induced hypoprolactinemia is usually reversible after dose reduction of the offending medication. The most common clinical scenario of drug-induced hypoprolactinemia in the endocrine clinic pertains to patients treated with cabergoline or bromocriptine for prolactin-secreting or other types of pituitary adenomas. Also, data has accumulated regarding hypoprolactinemia in patients receiving aripiprazole for schizophrenia and other psychiatric disorders. These patients warrant careful evaluation for comorbidities. This review aims to increase awareness about the potentially detrimental effects of drug-induced hypoprolactinemia, which should be considered in clinical practice decisions.

References

Karaca Z, Laway B, Dokmetas H, Atmaca H, Kelestimur F . Sheehan syndrome. Nat Rev Dis Primers. 2016; 2:16092. DOI: 10.1038/nrdp.2016.92. View

Freeman M, Kanyicska B, Lerant A, Nagy G . Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000; 80(4):1523-631. DOI: 10.1152/physrev.2000.80.4.1523. View

Maseroli E, Verde N, Cipriani S, Rastrelli G, Alfaroli C, Ravelli S . Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile. J Endocrinol Invest. 2023; 46(12):2481-2492. PMC: 10632269. DOI: 10.1007/s40618-023-02101-8. View

Spaggiari G, Costantino F, Granata A, Tagliavini S, Canu G, Varani M . Prolactin and spermatogenesis: new lights on the interplay between prolactin and sperm parameters. Endocrine. 2023; 81(2):330-339. DOI: 10.1007/s12020-023-03375-x. View

Corona G, Wu F, Rastrelli G, Lee D, Forti G, OConnor D . Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). J Sex Med. 2013; 11(1):240-53. DOI: 10.1111/jsm.12327. View

Munro V, Wilkinson M, Imran S . Neuropsychological complications of hypoprolactinemia. Rev Endocr Metab Disord. 2024; 25(6):1121-1126. DOI: 10.1007/s11154-024-09892-y. View

Grattan D . 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis. J Endocrinol. 2015; 226(2):T101-22. PMC: 4515538. DOI: 10.1530/JOE-15-0213. View

Veldhuis J, Johnson M . Operating characteristics of the hypothalamo-pituitary-gonadal axis in men: circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab. 1988; 67(1):116-23. DOI: 10.1210/jcem-67-1-116. View

Ben-Jonathan N, Mershon J, Allen D, Steinmetz R . Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996; 17(6):639-69. DOI: 10.1210/edrv-17-6-639. View

10.

Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F . Pregnancy and pituitary disorders. Eur J Endocrinol. 2009; 162(3):453-75. DOI: 10.1530/EJE-09-0923. View

11.

Scheithauer B, Sano T, Kovacs K, Young Jr W, Ryan N, Randall R . The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc. 1990; 65(4):461-74. DOI: 10.1016/s0025-6196(12)60946-x. View

12.

Bernard V, Young J, Binart N . Prolactin - a pleiotropic factor in health and disease. Nat Rev Endocrinol. 2019; 15(6):356-365. DOI: 10.1038/s41574-019-0194-6. View

13.

Schock H, Zeleniuch-Jacquotte A, Lundin E, Grankvist K, Lakso H, Idahl A . Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy Childbirth. 2016; 16(1):146. PMC: 4932669. DOI: 10.1186/s12884-016-0937-5. View

14.

Lamberts S, MacLeod R . Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev. 1990; 70(2):279-318. DOI: 10.1152/physrev.1990.70.2.279. View

15.

Ben-Jonathan N, Hnasko R . Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001; 22(6):724-63. DOI: 10.1210/edrv.22.6.0451. View

16.

Phillipps H, Yip S, Grattan D . Patterns of prolactin secretion. Mol Cell Endocrinol. 2019; 502:110679. DOI: 10.1016/j.mce.2019.110679. View

17.

Holzbauer M, Racke K . The dopaminergic innervation of the intermediate lobe and of the neural lobe of the pituitary gland. Med Biol. 1985; 63(3):97-116. View

18.

Peters L, Hoefer M, Ben-Jonathan N . The posterior pituitary: regulation of anterior pituitary prolactin secretion. Science. 1981; 213(4508):659-61. DOI: 10.1126/science.7256264. View

19.

Clarkson J, Han S, Piet R, McLennan T, Kane G, Ng J . Definition of the hypothalamic GnRH pulse generator in mice. Proc Natl Acad Sci U S A. 2017; 114(47):E10216-E10223. PMC: 5703322. DOI: 10.1073/pnas.1713897114. View

20.

Kokay I, Petersen S, Grattan D . Identification of prolactin-sensitive GABA and kisspeptin neurons in regions of the rat hypothalamus involved in the control of fertility. Endocrinology. 2010; 152(2):526-35. DOI: 10.1210/en.2010-0668. View